nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—SULT1E1—hematopoietic system—stomach cancer	0.0369	0.193	CbGeAlD
Cyclizine—SULT1E1—lymphoid tissue—stomach cancer	0.026	0.136	CbGeAlD
Cyclizine—SULT1E1—digestive system—stomach cancer	0.0257	0.134	CbGeAlD
Cyclizine—SULT1E1—endocrine gland—stomach cancer	0.0212	0.111	CbGeAlD
Cyclizine—SULT1E1—liver—stomach cancer	0.0191	0.0998	CbGeAlD
Cyclizine—CYP2C9—Capecitabine—stomach cancer	0.0169	0.628	CbGbCtD
Cyclizine—Thrombophlebitis—Floxuridine—stomach cancer	0.0147	0.0277	CcSEcCtD
Cyclizine—SULT1E1—lymph node—stomach cancer	0.0147	0.0765	CbGeAlD
Cyclizine—Disorientation—Floxuridine—stomach cancer	0.0142	0.0268	CcSEcCtD
Cyclizine—Injection site reaction—Mitomycin—stomach cancer	0.0137	0.0258	CcSEcCtD
Cyclizine—Thrombophlebitis—Mitomycin—stomach cancer	0.0115	0.0217	CcSEcCtD
Cyclizine—CYP2C9—Fluorouracil—stomach cancer	0.01	0.372	CbGbCtD
Cyclizine—Hepatitis cholestatic—Capecitabine—stomach cancer	0.00993	0.0187	CcSEcCtD
Cyclizine—Agranulocytosis—Floxuridine—stomach cancer	0.00915	0.0173	CcSEcCtD
Cyclizine—Altered state of consciousness—Capecitabine—stomach cancer	0.00866	0.0163	CcSEcCtD
Cyclizine—Blister—Fluorouracil—stomach cancer	0.00794	0.015	CcSEcCtD
Cyclizine—Drowsiness—Mitomycin—stomach cancer	0.00769	0.0145	CcSEcCtD
Cyclizine—Erythema—Floxuridine—stomach cancer	0.00766	0.0144	CcSEcCtD
Cyclizine—Muscle spasms—Floxuridine—stomach cancer	0.00737	0.0139	CcSEcCtD
Cyclizine—Speech disorder—Irinotecan—stomach cancer	0.00694	0.0131	CcSEcCtD
Cyclizine—CYP2C9—hematopoietic system—stomach cancer	0.00669	0.0349	CbGeAlD
Cyclizine—Speech disorder—Fluorouracil—stomach cancer	0.00665	0.0125	CcSEcCtD
Cyclizine—HRH1—hematopoietic system—stomach cancer	0.0066	0.0344	CbGeAlD
Cyclizine—Anaphylactic shock—Floxuridine—stomach cancer	0.00625	0.0118	CcSEcCtD
Cyclizine—Nervous system disorder—Floxuridine—stomach cancer	0.00613	0.0116	CcSEcCtD
Cyclizine—HRH1—epithelium—stomach cancer	0.00603	0.0315	CbGeAlD
Cyclizine—Erythema—Mitomycin—stomach cancer	0.00601	0.0113	CcSEcCtD
Cyclizine—HRH1—smooth muscle tissue—stomach cancer	0.00581	0.0303	CbGeAlD
Cyclizine—Vision blurred—Mitomycin—stomach cancer	0.00567	0.0107	CcSEcCtD
Cyclizine—Blister—Capecitabine—stomach cancer	0.00555	0.0105	CcSEcCtD
Cyclizine—Hypertension—Mitomycin—stomach cancer	0.00519	0.00979	CcSEcCtD
Cyclizine—Thrombophlebitis—Irinotecan—stomach cancer	0.00501	0.00945	CcSEcCtD
Cyclizine—Thrombophlebitis—Fluorouracil—stomach cancer	0.0048	0.00905	CcSEcCtD
Cyclizine—CYP2C9—digestive system—stomach cancer	0.00465	0.0243	CbGeAlD
Cyclizine—Disorientation—Fluorouracil—stomach cancer	0.00464	0.00875	CcSEcCtD
Cyclizine—Hypersensitivity—Floxuridine—stomach cancer	0.00461	0.00869	CcSEcCtD
Cyclizine—HRH1—digestive system—stomach cancer	0.00459	0.0239	CbGeAlD
Cyclizine—Asthenia—Floxuridine—stomach cancer	0.00449	0.00846	CcSEcCtD
Cyclizine—Somnolence—Mitomycin—stomach cancer	0.00436	0.00823	CcSEcCtD
Cyclizine—Dermatitis bullous—Fluorouracil—stomach cancer	0.00435	0.00819	CcSEcCtD
Cyclizine—Pain—Mitomycin—stomach cancer	0.0042	0.00791	CcSEcCtD
Cyclizine—Cinnarizine—HRH4—stomach cancer	0.00411	0.176	CrCbGaD
Cyclizine—Injection site reaction—Docetaxel—stomach cancer	0.0041	0.00774	CcSEcCtD
Cyclizine—Injection site reaction—Capecitabine—stomach cancer	0.00397	0.00749	CcSEcCtD
Cyclizine—Headache—Floxuridine—stomach cancer	0.00392	0.00739	CcSEcCtD
Cyclizine—Blister—Epirubicin—stomach cancer	0.00386	0.00729	CcSEcCtD
Cyclizine—Depressed level of consciousness—Capecitabine—stomach cancer	0.00386	0.00728	CcSEcCtD
Cyclizine—CYP2C9—endocrine gland—stomach cancer	0.00385	0.0201	CbGeAlD
Cyclizine—HRH1—endocrine gland—stomach cancer	0.00379	0.0198	CbGeAlD
Cyclizine—Blister—Doxorubicin—stomach cancer	0.00358	0.00674	CcSEcCtD
Cyclizine—Mianserin—HRH4—stomach cancer	0.00357	0.153	CrCbGaD
Cyclizine—Asthenia—Mitomycin—stomach cancer	0.00352	0.00664	CcSEcCtD
Cyclizine—Apnoea—Methotrexate—stomach cancer	0.00351	0.00662	CcSEcCtD
Cyclizine—CYP2C9—liver—stomach cancer	0.00347	0.0181	CbGeAlD
Cyclizine—Thrombophlebitis—Docetaxel—stomach cancer	0.00346	0.00653	CcSEcCtD
Cyclizine—Speech disorder—Methotrexate—stomach cancer	0.00346	0.00652	CcSEcCtD
Cyclizine—Thrombophlebitis—Capecitabine—stomach cancer	0.00335	0.00632	CcSEcCtD
Cyclizine—Hepatic function abnormal—Capecitabine—stomach cancer	0.00332	0.00626	CcSEcCtD
Cyclizine—Dizziness—Mitomycin—stomach cancer	0.00325	0.00612	CcSEcCtD
Cyclizine—Jaundice cholestatic—Epirubicin—stomach cancer	0.00317	0.00598	CcSEcCtD
Cyclizine—Dermatitis bullous—Docetaxel—stomach cancer	0.00314	0.00591	CcSEcCtD
Cyclizine—Headache—Mitomycin—stomach cancer	0.00307	0.0058	CcSEcCtD
Cyclizine—Dermatitis bullous—Capecitabine—stomach cancer	0.00304	0.00573	CcSEcCtD
Cyclizine—Agranulocytosis—Fluorouracil—stomach cancer	0.00299	0.00563	CcSEcCtD
Cyclizine—Dyskinesia—Epirubicin—stomach cancer	0.00296	0.00559	CcSEcCtD
Cyclizine—Connective tissue disorder—Irinotecan—stomach cancer	0.00295	0.00556	CcSEcCtD
Cyclizine—Jaundice cholestatic—Doxorubicin—stomach cancer	0.00293	0.00553	CcSEcCtD
Cyclizine—Depressed level of consciousness—Methotrexate—stomach cancer	0.00287	0.00542	CcSEcCtD
Cyclizine—Loxapine—HRH4—stomach cancer	0.00284	0.122	CrCbGaD
Cyclizine—Injection site reaction—Epirubicin—stomach cancer	0.00277	0.00522	CcSEcCtD
Cyclizine—Urinary retention—Capecitabine—stomach cancer	0.00276	0.0052	CcSEcCtD
Cyclizine—Dyskinesia—Doxorubicin—stomach cancer	0.00274	0.00517	CcSEcCtD
Cyclizine—Chills—Irinotecan—stomach cancer	0.00269	0.00508	CcSEcCtD
Cyclizine—HRH1—lymph node—stomach cancer	0.00262	0.0137	CbGeAlD
Cyclizine—Injection site reaction—Doxorubicin—stomach cancer	0.00256	0.00483	CcSEcCtD
Cyclizine—Bronchospasm—Docetaxel—stomach cancer	0.00255	0.00481	CcSEcCtD
Cyclizine—Muscle spasms—Irinotecan—stomach cancer	0.00251	0.00473	CcSEcCtD
Cyclizine—Erythema—Fluorouracil—stomach cancer	0.0025	0.00472	CcSEcCtD
Cyclizine—Thrombophlebitis—Methotrexate—stomach cancer	0.0025	0.00471	CcSEcCtD
Cyclizine—Bronchospasm—Capecitabine—stomach cancer	0.00247	0.00465	CcSEcCtD
Cyclizine—Clozapine—HRH4—stomach cancer	0.00238	0.102	CrCbGaD
Cyclizine—Vision blurred—Fluorouracil—stomach cancer	0.00236	0.00444	CcSEcCtD
Cyclizine—Thrombophlebitis—Epirubicin—stomach cancer	0.00234	0.0044	CcSEcCtD
Cyclizine—Hepatic function abnormal—Epirubicin—stomach cancer	0.00231	0.00436	CcSEcCtD
Cyclizine—Hypertension—Irinotecan—stomach cancer	0.00225	0.00425	CcSEcCtD
Cyclizine—Hepatobiliary disease—Docetaxel—stomach cancer	0.00218	0.00412	CcSEcCtD
Cyclizine—Convulsion—Fluorouracil—stomach cancer	0.00217	0.00409	CcSEcCtD
Cyclizine—Thrombophlebitis—Doxorubicin—stomach cancer	0.00216	0.00407	CcSEcCtD
Cyclizine—Agranulocytosis—Docetaxel—stomach cancer	0.00216	0.00406	CcSEcCtD
Cyclizine—Hepatic function abnormal—Doxorubicin—stomach cancer	0.00214	0.00404	CcSEcCtD
Cyclizine—Anaphylactic shock—Irinotecan—stomach cancer	0.00213	0.00402	CcSEcCtD
Cyclizine—Dermatitis bullous—Epirubicin—stomach cancer	0.00212	0.00399	CcSEcCtD
Cyclizine—Hepatobiliary disease—Capecitabine—stomach cancer	0.00212	0.00399	CcSEcCtD
Cyclizine—Nervous system disorder—Irinotecan—stomach cancer	0.00209	0.00394	CcSEcCtD
Cyclizine—Agranulocytosis—Capecitabine—stomach cancer	0.00209	0.00394	CcSEcCtD
Cyclizine—Hepatitis—Docetaxel—stomach cancer	0.00207	0.00391	CcSEcCtD
Cyclizine—Anaphylactic shock—Fluorouracil—stomach cancer	0.00204	0.00385	CcSEcCtD
Cyclizine—Connective tissue disorder—Docetaxel—stomach cancer	0.00204	0.00384	CcSEcCtD
Cyclizine—Hepatitis—Capecitabine—stomach cancer	0.00201	0.00379	CcSEcCtD
Cyclizine—Nervous system disorder—Fluorouracil—stomach cancer	0.002	0.00377	CcSEcCtD
Cyclizine—Tachycardia—Fluorouracil—stomach cancer	0.00199	0.00376	CcSEcCtD
Cyclizine—Hypotension—Irinotecan—stomach cancer	0.00199	0.00376	CcSEcCtD
Cyclizine—Connective tissue disorder—Capecitabine—stomach cancer	0.00197	0.00372	CcSEcCtD
Cyclizine—Dermatitis bullous—Doxorubicin—stomach cancer	0.00196	0.00369	CcSEcCtD
Cyclizine—Eye disorder—Docetaxel—stomach cancer	0.00194	0.00365	CcSEcCtD
Cyclizine—Insomnia—Irinotecan—stomach cancer	0.00193	0.00363	CcSEcCtD
Cyclizine—Paraesthesia—Irinotecan—stomach cancer	0.00191	0.00361	CcSEcCtD
Cyclizine—Hypotension—Fluorouracil—stomach cancer	0.00191	0.0036	CcSEcCtD
Cyclizine—Somnolence—Irinotecan—stomach cancer	0.00189	0.00357	CcSEcCtD
Cyclizine—Eye disorder—Capecitabine—stomach cancer	0.00188	0.00354	CcSEcCtD
Cyclizine—Chills—Docetaxel—stomach cancer	0.00186	0.00351	CcSEcCtD
Cyclizine—Insomnia—Fluorouracil—stomach cancer	0.00185	0.00348	CcSEcCtD
Cyclizine—Paraesthesia—Fluorouracil—stomach cancer	0.00183	0.00346	CcSEcCtD
Cyclizine—Constipation—Irinotecan—stomach cancer	0.00182	0.00344	CcSEcCtD
Cyclizine—Pain—Irinotecan—stomach cancer	0.00182	0.00344	CcSEcCtD
Cyclizine—Mental disorder—Docetaxel—stomach cancer	0.00182	0.00343	CcSEcCtD
Cyclizine—Somnolence—Fluorouracil—stomach cancer	0.00181	0.00342	CcSEcCtD
Cyclizine—Erythema—Docetaxel—stomach cancer	0.00181	0.0034	CcSEcCtD
Cyclizine—Chills—Capecitabine—stomach cancer	0.0018	0.0034	CcSEcCtD
Cyclizine—Mental disorder—Capecitabine—stomach cancer	0.00176	0.00332	CcSEcCtD
Cyclizine—Erythema—Capecitabine—stomach cancer	0.00175	0.0033	CcSEcCtD
Cyclizine—Pain—Fluorouracil—stomach cancer	0.00175	0.00329	CcSEcCtD
Cyclizine—Muscle spasms—Docetaxel—stomach cancer	0.00174	0.00327	CcSEcCtD
Cyclizine—Flunarizine—CYP2A6—stomach cancer	0.00173	0.0741	CrCbGaD
Cyclizine—Muscle spasms—Capecitabine—stomach cancer	0.00168	0.00317	CcSEcCtD
Cyclizine—Drowsiness—Methotrexate—stomach cancer	0.00166	0.00314	CcSEcCtD
Cyclizine—Vision blurred—Capecitabine—stomach cancer	0.00165	0.00311	CcSEcCtD
Cyclizine—Tremor—Capecitabine—stomach cancer	0.00164	0.00309	CcSEcCtD
Cyclizine—Urticaria—Fluorouracil—stomach cancer	0.00162	0.00306	CcSEcCtD
Cyclizine—Hepatobiliary disease—Methotrexate—stomach cancer	0.00157	0.00297	CcSEcCtD
Cyclizine—Hypersensitivity—Irinotecan—stomach cancer	0.00157	0.00296	CcSEcCtD
Cyclizine—Convulsion—Docetaxel—stomach cancer	0.00156	0.00295	CcSEcCtD
Cyclizine—Hypertension—Docetaxel—stomach cancer	0.00156	0.00294	CcSEcCtD
Cyclizine—Drowsiness—Epirubicin—stomach cancer	0.00156	0.00294	CcSEcCtD
Cyclizine—Agranulocytosis—Methotrexate—stomach cancer	0.00155	0.00293	CcSEcCtD
Cyclizine—Asthenia—Irinotecan—stomach cancer	0.00153	0.00288	CcSEcCtD
Cyclizine—Hypertension—Capecitabine—stomach cancer	0.00151	0.00285	CcSEcCtD
Cyclizine—Hypersensitivity—Fluorouracil—stomach cancer	0.0015	0.00284	CcSEcCtD
Cyclizine—Hepatitis—Methotrexate—stomach cancer	0.00149	0.00282	CcSEcCtD
Cyclizine—Hepatobiliary disease—Epirubicin—stomach cancer	0.00147	0.00278	CcSEcCtD
Cyclizine—Anaphylactic shock—Docetaxel—stomach cancer	0.00147	0.00278	CcSEcCtD
Cyclizine—Agranulocytosis—Epirubicin—stomach cancer	0.00145	0.00274	CcSEcCtD
Cyclizine—Nervous system disorder—Docetaxel—stomach cancer	0.00144	0.00272	CcSEcCtD
Cyclizine—Pruritus—Fluorouracil—stomach cancer	0.00144	0.00272	CcSEcCtD
Cyclizine—Drowsiness—Doxorubicin—stomach cancer	0.00144	0.00272	CcSEcCtD
Cyclizine—Tachycardia—Docetaxel—stomach cancer	0.00144	0.00271	CcSEcCtD
Cyclizine—Skin disorder—Docetaxel—stomach cancer	0.00143	0.0027	CcSEcCtD
Cyclizine—Dizziness—Irinotecan—stomach cancer	0.00141	0.00266	CcSEcCtD
Cyclizine—Nervous system disorder—Capecitabine—stomach cancer	0.0014	0.00264	CcSEcCtD
Cyclizine—Hepatitis—Epirubicin—stomach cancer	0.0014	0.00264	CcSEcCtD
Cyclizine—Eye disorder—Methotrexate—stomach cancer	0.0014	0.00263	CcSEcCtD
Cyclizine—Tachycardia—Capecitabine—stomach cancer	0.00139	0.00263	CcSEcCtD
Cyclizine—Skin disorder—Capecitabine—stomach cancer	0.00139	0.00261	CcSEcCtD
Cyclizine—Hypotension—Docetaxel—stomach cancer	0.00138	0.0026	CcSEcCtD
Cyclizine—Connective tissue disorder—Epirubicin—stomach cancer	0.00137	0.00259	CcSEcCtD
Cyclizine—Cinnarizine—CYP2A6—stomach cancer	0.00137	0.0586	CrCbGaD
Cyclizine—Hepatobiliary disease—Doxorubicin—stomach cancer	0.00136	0.00257	CcSEcCtD
Cyclizine—Cyproheptadine—HTR1A—stomach cancer	0.00136	0.0584	CrCbGaD
Cyclizine—Dizziness—Fluorouracil—stomach cancer	0.00135	0.00255	CcSEcCtD
Cyclizine—Agranulocytosis—Doxorubicin—stomach cancer	0.00135	0.00254	CcSEcCtD
Cyclizine—Chills—Methotrexate—stomach cancer	0.00134	0.00253	CcSEcCtD
Cyclizine—Headache—Irinotecan—stomach cancer	0.00134	0.00252	CcSEcCtD
Cyclizine—Hypotension—Capecitabine—stomach cancer	0.00133	0.00251	CcSEcCtD
Cyclizine—Insomnia—Docetaxel—stomach cancer	0.00133	0.00251	CcSEcCtD
Cyclizine—Paraesthesia—Docetaxel—stomach cancer	0.00132	0.00249	CcSEcCtD
Cyclizine—Somnolence—Docetaxel—stomach cancer	0.00131	0.00247	CcSEcCtD
Cyclizine—Mental disorder—Methotrexate—stomach cancer	0.00131	0.00247	CcSEcCtD
Cyclizine—Eye disorder—Epirubicin—stomach cancer	0.00131	0.00246	CcSEcCtD
Cyclizine—Erythema—Methotrexate—stomach cancer	0.0013	0.00245	CcSEcCtD
Cyclizine—Hepatitis—Doxorubicin—stomach cancer	0.00129	0.00244	CcSEcCtD
Cyclizine—Insomnia—Capecitabine—stomach cancer	0.00129	0.00243	CcSEcCtD
Cyclizine—Paraesthesia—Capecitabine—stomach cancer	0.00128	0.00242	CcSEcCtD
Cyclizine—Headache—Fluorouracil—stomach cancer	0.00128	0.00241	CcSEcCtD
Cyclizine—Connective tissue disorder—Doxorubicin—stomach cancer	0.00127	0.0024	CcSEcCtD
Cyclizine—Constipation—Docetaxel—stomach cancer	0.00126	0.00238	CcSEcCtD
Cyclizine—Pain—Docetaxel—stomach cancer	0.00126	0.00238	CcSEcCtD
Cyclizine—Chills—Epirubicin—stomach cancer	0.00125	0.00237	CcSEcCtD
Cyclizine—Vision blurred—Methotrexate—stomach cancer	0.00123	0.00231	CcSEcCtD
Cyclizine—Mental disorder—Epirubicin—stomach cancer	0.00123	0.00231	CcSEcCtD
Cyclizine—Constipation—Capecitabine—stomach cancer	0.00122	0.0023	CcSEcCtD
Cyclizine—Pain—Capecitabine—stomach cancer	0.00122	0.0023	CcSEcCtD
Cyclizine—Erythema—Epirubicin—stomach cancer	0.00122	0.0023	CcSEcCtD
Cyclizine—Eye disorder—Doxorubicin—stomach cancer	0.00121	0.00228	CcSEcCtD
Cyclizine—Tension—Epirubicin—stomach cancer	0.00119	0.00225	CcSEcCtD
Cyclizine—Nervousness—Epirubicin—stomach cancer	0.00118	0.00223	CcSEcCtD
Cyclizine—Muscle spasms—Epirubicin—stomach cancer	0.00117	0.00221	CcSEcCtD
Cyclizine—Chills—Doxorubicin—stomach cancer	0.00116	0.00219	CcSEcCtD
Cyclizine—Vision blurred—Epirubicin—stomach cancer	0.00115	0.00216	CcSEcCtD
Cyclizine—Mental disorder—Doxorubicin—stomach cancer	0.00113	0.00214	CcSEcCtD
Cyclizine—Urticaria—Capecitabine—stomach cancer	0.00113	0.00214	CcSEcCtD
Cyclizine—Convulsion—Methotrexate—stomach cancer	0.00113	0.00213	CcSEcCtD
Cyclizine—Erythema—Doxorubicin—stomach cancer	0.00113	0.00212	CcSEcCtD
Cyclizine—Agitation—Epirubicin—stomach cancer	0.00112	0.00211	CcSEcCtD
Cyclizine—Tension—Doxorubicin—stomach cancer	0.00111	0.00208	CcSEcCtD
Cyclizine—Nervousness—Doxorubicin—stomach cancer	0.00109	0.00206	CcSEcCtD
Cyclizine—Hypersensitivity—Docetaxel—stomach cancer	0.00109	0.00205	CcSEcCtD
Cyclizine—Muscle spasms—Doxorubicin—stomach cancer	0.00108	0.00204	CcSEcCtD
Cyclizine—Anaphylactic shock—Methotrexate—stomach cancer	0.00106	0.002	CcSEcCtD
Cyclizine—Vision blurred—Doxorubicin—stomach cancer	0.00106	0.002	CcSEcCtD
Cyclizine—Asthenia—Docetaxel—stomach cancer	0.00106	0.00199	CcSEcCtD
Cyclizine—Convulsion—Epirubicin—stomach cancer	0.00105	0.00199	CcSEcCtD
Cyclizine—Hypertension—Epirubicin—stomach cancer	0.00105	0.00198	CcSEcCtD
Cyclizine—Hypersensitivity—Capecitabine—stomach cancer	0.00105	0.00198	CcSEcCtD
Cyclizine—Pruritus—Docetaxel—stomach cancer	0.00104	0.00197	CcSEcCtD
Cyclizine—Nervous system disorder—Methotrexate—stomach cancer	0.00104	0.00196	CcSEcCtD
Cyclizine—Agitation—Doxorubicin—stomach cancer	0.00104	0.00195	CcSEcCtD
Cyclizine—Mianserin—HTR1A—stomach cancer	0.00103	0.0443	CrCbGaD
Cyclizine—Skin disorder—Methotrexate—stomach cancer	0.00103	0.00194	CcSEcCtD
Cyclizine—Asthenia—Capecitabine—stomach cancer	0.00102	0.00193	CcSEcCtD
Cyclizine—Pruritus—Capecitabine—stomach cancer	0.00101	0.0019	CcSEcCtD
Cyclizine—Anaphylactic shock—Epirubicin—stomach cancer	0.000994	0.00187	CcSEcCtD
Cyclizine—Hypotension—Methotrexate—stomach cancer	0.000992	0.00187	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—PDHA1—stomach cancer	0.000987	0.00433	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—ECHS1—stomach cancer	0.000987	0.00433	CbGpPWpGaD
Cyclizine—Convulsion—Doxorubicin—stomach cancer	0.000976	0.00184	CcSEcCtD
Cyclizine—Nervous system disorder—Epirubicin—stomach cancer	0.000974	0.00184	CcSEcCtD
Cyclizine—Dizziness—Docetaxel—stomach cancer	0.000974	0.00184	CcSEcCtD
Cyclizine—Hypertension—Doxorubicin—stomach cancer	0.000973	0.00183	CcSEcCtD
Cyclizine—Tachycardia—Epirubicin—stomach cancer	0.00097	0.00183	CcSEcCtD
Cyclizine—Skin disorder—Epirubicin—stomach cancer	0.000965	0.00182	CcSEcCtD
Cyclizine—Insomnia—Methotrexate—stomach cancer	0.00096	0.00181	CcSEcCtD
Cyclizine—Phenoxybenzamine—ADRB2—stomach cancer	0.000957	0.041	CrCbGaD
Cyclizine—Paraesthesia—Methotrexate—stomach cancer	0.000953	0.0018	CcSEcCtD
Cyclizine—Somnolence—Methotrexate—stomach cancer	0.000944	0.00178	CcSEcCtD
Cyclizine—Dizziness—Capecitabine—stomach cancer	0.000943	0.00178	CcSEcCtD
Cyclizine—HRH1—IL-4 Signaling Pathway—IRS2—stomach cancer	0.000942	0.00414	CbGpPWpGaD
Cyclizine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.000941	0.00413	CbGpPWpGaD
Cyclizine—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000929	0.00408	CbGpPWpGaD
Cyclizine—Hypotension—Epirubicin—stomach cancer	0.000929	0.00175	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—TYMP—stomach cancer	0.000928	0.00407	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—FADS1—stomach cancer	0.000928	0.00407	CbGpPWpGaD
Cyclizine—Headache—Docetaxel—stomach cancer	0.000923	0.00174	CcSEcCtD
Cyclizine—Anaphylactic shock—Doxorubicin—stomach cancer	0.000919	0.00173	CcSEcCtD
Cyclizine—Loxapine—ADRB1—stomach cancer	0.000917	0.0393	CrCbGaD
Cyclizine—Pain—Methotrexate—stomach cancer	0.000908	0.00171	CcSEcCtD
Cyclizine—Nervous system disorder—Doxorubicin—stomach cancer	0.000902	0.0017	CcSEcCtD
Cyclizine—Insomnia—Epirubicin—stomach cancer	0.000899	0.00169	CcSEcCtD
Cyclizine—Tachycardia—Doxorubicin—stomach cancer	0.000897	0.00169	CcSEcCtD
Cyclizine—Headache—Capecitabine—stomach cancer	0.000894	0.00168	CcSEcCtD
Cyclizine—Skin disorder—Doxorubicin—stomach cancer	0.000893	0.00168	CcSEcCtD
Cyclizine—Paraesthesia—Epirubicin—stomach cancer	0.000892	0.00168	CcSEcCtD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—stomach cancer	0.000883	0.00388	CbGpPWpGaD
Cyclizine—Somnolence—Epirubicin—stomach cancer	0.000883	0.00167	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—SREBF2—stomach cancer	0.000869	0.00381	CbGpPWpGaD
Cyclizine—Hypotension—Doxorubicin—stomach cancer	0.000859	0.00162	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—RORA—stomach cancer	0.000858	0.00377	CbGpPWpGaD
Cyclizine—Pain—Epirubicin—stomach cancer	0.00085	0.0016	CcSEcCtD
Cyclizine—Constipation—Epirubicin—stomach cancer	0.00085	0.0016	CcSEcCtD
Cyclizine—HRH1—G alpha (q) signalling events—RGS2—stomach cancer	0.000849	0.00373	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—GAST—stomach cancer	0.000849	0.00373	CbGpPWpGaD
Cyclizine—Urticaria—Methotrexate—stomach cancer	0.000844	0.00159	CcSEcCtD
Cyclizine—Insomnia—Doxorubicin—stomach cancer	0.000832	0.00157	CcSEcCtD
Cyclizine—Paraesthesia—Doxorubicin—stomach cancer	0.000826	0.00156	CcSEcCtD
Cyclizine—Loxapine—HTR1A—stomach cancer	0.00082	0.0352	CrCbGaD
Cyclizine—Somnolence—Doxorubicin—stomach cancer	0.000817	0.00154	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—ALDOB—stomach cancer	0.000804	0.00353	CbGpPWpGaD
Cyclizine—Clozapine—CYP2A6—stomach cancer	0.000793	0.034	CrCbGaD
Cyclizine—Urticaria—Epirubicin—stomach cancer	0.000789	0.00149	CcSEcCtD
Cyclizine—Constipation—Doxorubicin—stomach cancer	0.000786	0.00148	CcSEcCtD
Cyclizine—Pain—Doxorubicin—stomach cancer	0.000786	0.00148	CcSEcCtD
Cyclizine—Hypersensitivity—Methotrexate—stomach cancer	0.000782	0.00148	CcSEcCtD
Cyclizine—HRH1—GPCR ligand binding—KISS1R—stomach cancer	0.000773	0.00339	CbGpPWpGaD
Cyclizine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000763	0.00335	CbGpPWpGaD
Cyclizine—Asthenia—Methotrexate—stomach cancer	0.000762	0.00144	CcSEcCtD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—stomach cancer	0.00076	0.00334	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RGS2—stomach cancer	0.00076	0.00334	CbGpPWpGaD
Cyclizine—Phenprocoumon—ALB—stomach cancer	0.000759	0.0325	CrCbGaD
Cyclizine—Pruritus—Methotrexate—stomach cancer	0.000751	0.00142	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—ALOX5—stomach cancer	0.000748	0.00328	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—DPYD—stomach cancer	0.000736	0.00323	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH4—stomach cancer	0.000734	0.00322	CbGpPWpGaD
Cyclizine—Hypersensitivity—Epirubicin—stomach cancer	0.000732	0.00138	CcSEcCtD
Cyclizine—Urticaria—Doxorubicin—stomach cancer	0.00073	0.00138	CcSEcCtD
Cyclizine—Asthenia—Epirubicin—stomach cancer	0.000713	0.00134	CcSEcCtD
Cyclizine—Pruritus—Epirubicin—stomach cancer	0.000703	0.00133	CcSEcCtD
Cyclizine—Dizziness—Methotrexate—stomach cancer	0.000702	0.00132	CcSEcCtD
Cyclizine—Clozapine—HTR1A—stomach cancer	0.000689	0.0295	CrCbGaD
Cyclizine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000685	0.00301	CbGpPWpGaD
Cyclizine—Hypersensitivity—Doxorubicin—stomach cancer	0.000677	0.00128	CcSEcCtD
Cyclizine—Headache—Methotrexate—stomach cancer	0.000665	0.00125	CcSEcCtD
Cyclizine—Asthenia—Doxorubicin—stomach cancer	0.00066	0.00124	CcSEcCtD
Cyclizine—Dizziness—Epirubicin—stomach cancer	0.000657	0.00124	CcSEcCtD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—KISS1—stomach cancer	0.000654	0.00287	CbGpPWpGaD
Cyclizine—Pruritus—Doxorubicin—stomach cancer	0.00065	0.00123	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—GSTT1—stomach cancer	0.00065	0.00286	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CYP2A6—stomach cancer	0.000643	0.00282	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—F2R—stomach cancer	0.000636	0.00279	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—AKR1C3—stomach cancer	0.000625	0.00275	CbGpPWpGaD
Cyclizine—Headache—Epirubicin—stomach cancer	0.000623	0.00117	CcSEcCtD
Cyclizine—SULT1E1—Metabolism—ENO1—stomach cancer	0.00061	0.00268	CbGpPWpGaD
Cyclizine—Dizziness—Doxorubicin—stomach cancer	0.000608	0.00115	CcSEcCtD
Cyclizine—HRH1—G alpha (q) signalling events—ANXA1—stomach cancer	0.000598	0.00263	CbGpPWpGaD
Cyclizine—Headache—Doxorubicin—stomach cancer	0.000576	0.00109	CcSEcCtD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2R—stomach cancer	0.000569	0.0025	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—HRH4—stomach cancer	0.000559	0.00245	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CD44—stomach cancer	0.000541	0.00237	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—stomach cancer	0.000535	0.00235	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—KISS1—stomach cancer	0.000498	0.00219	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	0.000498	0.00218	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—STAT3—stomach cancer	0.000493	0.00216	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	0.000492	0.00216	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	0.000479	0.0021	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—MAPK3—stomach cancer	0.000471	0.00207	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PPP2R1A—stomach cancer	0.00046	0.00202	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HBEGF—stomach cancer	0.000455	0.002	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—GSTP1—stomach cancer	0.000451	0.00198	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB1—stomach cancer	0.000448	0.00197	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—MAPK1—stomach cancer	0.000448	0.00197	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—HMOX1—stomach cancer	0.000445	0.00195	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—KISS1R—stomach cancer	0.000437	0.00192	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	0.000426	0.00187	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	0.000422	0.00185	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—TYMS—stomach cancer	0.000419	0.00184	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—GSTM1—stomach cancer	0.000414	0.00182	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	0.00041	0.0018	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—GSTT1—stomach cancer	0.00041	0.0018	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—CYP2A6—stomach cancer	0.000405	0.00178	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—KISS1R—stomach cancer	0.000397	0.00174	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.000396	0.00174	CbGpPWpGaD
Cyclizine—CYP2C9—Arachidonic acid metabolism—PTGS2—stomach cancer	0.000396	0.00174	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—ERCC2—stomach cancer	0.00039	0.00171	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—AKR1C3—stomach cancer	0.000389	0.00171	CbGpPWpGaD
Cyclizine—HRH1—IL-4 Signaling Pathway—PIK3CA—stomach cancer	0.000389	0.00171	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.000384	0.00169	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—MTHFR—stomach cancer	0.000366	0.00161	CbGpPWpGaD
Cyclizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.000363	0.00159	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000354	0.00155	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—CAV1—stomach cancer	0.000338	0.00148	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—APOA1—stomach cancer	0.000337	0.00148	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—AGTR2—stomach cancer	0.000325	0.00143	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—F2R—stomach cancer	0.000321	0.00141	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—HRH4—stomach cancer	0.000316	0.00139	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—HTR1A—stomach cancer	0.000312	0.00137	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.000311	0.00137	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—ANXA1—stomach cancer	0.000302	0.00133	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PPARG—stomach cancer	0.000297	0.0013	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000296	0.0013	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—ADRB1—stomach cancer	0.000292	0.00128	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HRH4—stomach cancer	0.000287	0.00126	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—stomach cancer	0.000287	0.00126	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—GSTP1—stomach cancer	0.000284	0.00125	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—KISS1—stomach cancer	0.000282	0.00124	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—GSTP1—stomach cancer	0.00028	0.00123	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—ALB—stomach cancer	0.000267	0.00117	CbGpPWpGaD
Cyclizine—CYP2C9—Biological oxidations—GSTM1—stomach cancer	0.000261	0.00115	CbGpPWpGaD
Cyclizine—CYP2C9—Metapathway biotransformation—GSTM1—stomach cancer	0.000258	0.00113	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—stomach cancer	0.000256	0.00112	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—KISS1—stomach cancer	0.000256	0.00112	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—NOS3—stomach cancer	0.000255	0.00112	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ACAD8—stomach cancer	0.000244	0.00107	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—RGS2—stomach cancer	0.000242	0.00106	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—GAST—stomach cancer	0.000242	0.00106	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000239	0.00105	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—ADRB2—stomach cancer	0.000237	0.00104	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GLI3—stomach cancer	0.000234	0.00103	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KISS1R—stomach cancer	0.000234	0.00103	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PTGS2—stomach cancer	0.000234	0.00103	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000225	0.000986	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RBP1—stomach cancer	0.000224	0.000982	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—RGS2—stomach cancer	0.00022	0.000965	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GAST—stomach cancer	0.00022	0.000965	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GMPR2—stomach cancer	0.000218	0.000956	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.00021	0.000923	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000208	0.000912	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SUCLG1—stomach cancer	0.000199	0.000875	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—IDH3B—stomach cancer	0.000199	0.000875	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NDUFV1—stomach cancer	0.000185	0.000813	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NDUFS1—stomach cancer	0.000185	0.000813	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AGTR2—stomach cancer	0.000183	0.000806	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—WWOX—stomach cancer	0.000182	0.0008	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—F2R—stomach cancer	0.000181	0.000797	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.000181	0.000795	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—HTR1A—stomach cancer	0.000177	0.000775	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ANXA1—stomach cancer	0.000171	0.000749	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—WIF1—stomach cancer	0.000169	0.000744	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HRH4—stomach cancer	0.000169	0.000744	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AGTR2—stomach cancer	0.000167	0.000732	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ADRB1—stomach cancer	0.000165	0.000725	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PGLS—stomach cancer	0.000165	0.000725	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—BLVRB—stomach cancer	0.000165	0.000725	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—F2R—stomach cancer	0.000165	0.000723	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HTR1A—stomach cancer	0.00016	0.000704	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPAP2A—stomach cancer	0.000157	0.000691	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRKAB1—stomach cancer	0.000156	0.000687	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	0.000156	0.000684	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ANXA1—stomach cancer	0.000155	0.00068	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	0.000151	0.000665	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KISS1—stomach cancer	0.000151	0.000663	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RNF43—stomach cancer	0.000151	0.000663	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.00015	0.00066	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADRB1—stomach cancer	0.00015	0.000659	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	0.000148	0.000651	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	0.000148	0.000651	CbGpPWpGaD
Cyclizine—HRH1—G alpha (q) signalling events—PIK3CA—stomach cancer	0.000144	0.000632	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—PIK3CA—stomach cancer	0.000144	0.000631	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CA1—stomach cancer	0.00014	0.000616	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CKB—stomach cancer	0.00014	0.000616	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NDUFA2—stomach cancer	0.00014	0.000616	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—FBP1—stomach cancer	0.00014	0.000616	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.00014	0.000615	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FST—stomach cancer	0.000135	0.000591	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ADRB2—stomach cancer	0.000134	0.000588	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PLIN2—stomach cancer	0.000132	0.000579	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HBEGF—stomach cancer	0.000132	0.000578	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GAST—stomach cancer	0.00013	0.00057	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RGS2—stomach cancer	0.00013	0.00057	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	0.000129	0.000565	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CA2—stomach cancer	0.000128	0.000564	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NT5E—stomach cancer	0.000125	0.000549	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PGAM1—stomach cancer	0.000125	0.000549	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FGG—stomach cancer	0.000123	0.000541	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADRB2—stomach cancer	0.000122	0.000534	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALDH7A1—stomach cancer	0.000119	0.000524	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PLCE1—stomach cancer	0.000119	0.000524	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PPP2R1A—stomach cancer	0.000119	0.000523	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000119	0.000523	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRKAA1—stomach cancer	0.000119	0.00052	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RBP4—stomach cancer	0.000114	0.000503	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—UMPS—stomach cancer	0.000114	0.000502	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—CXCL8—stomach cancer	0.000114	0.000502	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	0.000114	0.0005	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PDHA1—stomach cancer	0.000106	0.000467	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ECHS1—stomach cancer	0.000106	0.000467	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—FADS1—stomach cancer	0.0001	0.000439	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—TYMP—stomach cancer	0.0001	0.000439	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HSPB1—stomach cancer	9.84e-05	0.000432	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AGTR2—stomach cancer	9.84e-05	0.000432	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—BMP2—stomach cancer	9.73e-05	0.000427	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—F2R—stomach cancer	9.73e-05	0.000427	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AKR1C3—stomach cancer	9.57e-05	0.00042	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HTR1A—stomach cancer	9.47e-05	0.000416	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SREBF2—stomach cancer	9.36e-05	0.000411	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—RORA—stomach cancer	9.25e-05	0.000406	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PRKCB—stomach cancer	9.17e-05	0.000403	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ANXA1—stomach cancer	9.15e-05	0.000402	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRB1—stomach cancer	8.86e-05	0.000389	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALDOB—stomach cancer	8.67e-05	0.000381	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RPS6—stomach cancer	8.47e-05	0.000372	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PRKCB—stomach cancer	8.33e-05	0.000366	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL6ST—stomach cancer	8.3e-05	0.000364	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	8.18e-05	0.000359	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	8.16e-05	0.000358	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALOX5—stomach cancer	8.06e-05	0.000354	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—DPYD—stomach cancer	7.93e-05	0.000348	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HBEGF—stomach cancer	7.78e-05	0.000342	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL6R—stomach cancer	7.4e-05	0.000325	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—RHOA—stomach cancer	7.36e-05	0.000323	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.19e-05	0.000316	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRB2—stomach cancer	7.18e-05	0.000315	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PPP2R1A—stomach cancer	7.04e-05	0.000309	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTT1—stomach cancer	7.01e-05	0.000308	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP2A6—stomach cancer	6.93e-05	0.000304	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AKR1C3—stomach cancer	6.74e-05	0.000296	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—RHOA—stomach cancer	6.69e-05	0.000294	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ENO1—stomach cancer	6.57e-05	0.000289	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SMAD4—stomach cancer	6.53e-05	0.000287	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CXCL8—stomach cancer	6.46e-05	0.000284	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.46e-05	0.000284	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FYN—stomach cancer	6.2e-05	0.000272	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CXCL8—stomach cancer	5.87e-05	0.000258	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CD44—stomach cancer	5.83e-05	0.000256	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FGFR2—stomach cancer	5.82e-05	0.000256	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.65e-05	0.000248	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IRS2—stomach cancer	5.33e-05	0.000234	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CAV1—stomach cancer	5.17e-05	0.000227	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APOA1—stomach cancer	5.16e-05	0.000227	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPP2R1A—stomach cancer	4.96e-05	0.000218	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRKCB—stomach cancer	4.92e-05	0.000216	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL6ST—stomach cancer	4.9e-05	0.000215	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTP1—stomach cancer	4.86e-05	0.000213	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HMOX1—stomach cancer	4.79e-05	0.000211	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APC—stomach cancer	4.71e-05	0.000207	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—TYMS—stomach cancer	4.52e-05	0.000198	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—MAPK3—stomach cancer	4.51e-05	0.000198	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTM1—stomach cancer	4.47e-05	0.000196	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL6R—stomach cancer	4.37e-05	0.000192	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—MAPK1—stomach cancer	4.29e-05	0.000188	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—EGFR—stomach cancer	4.29e-05	0.000188	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ERCC2—stomach cancer	4.2e-05	0.000184	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3CA—stomach cancer	4.1e-05	0.00018	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SERPINE1—stomach cancer	4.09e-05	0.00018	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—KRAS—stomach cancer	4.05e-05	0.000178	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RHOA—stomach cancer	3.95e-05	0.000173	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—MTHFR—stomach cancer	3.95e-05	0.000173	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NOS3—stomach cancer	3.91e-05	0.000172	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	3.72e-05	0.000164	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ERBB2—stomach cancer	3.66e-05	0.000161	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CAV1—stomach cancer	3.64e-05	0.00016	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APOA1—stomach cancer	3.63e-05	0.00016	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.48e-05	0.000153	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCL8—stomach cancer	3.47e-05	0.000152	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HRAS—stomach cancer	3.45e-05	0.000151	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CDKN1B—stomach cancer	3.39e-05	0.000149	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL6—stomach cancer	3.3e-05	0.000145	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCND1—stomach cancer	3.23e-05	0.000142	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—JUN—stomach cancer	3.22e-05	0.000142	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPARG—stomach cancer	3.2e-05	0.000141	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MMP9—stomach cancer	3.14e-05	0.000138	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CDKN1A—stomach cancer	3.13e-05	0.000137	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MAPK8—stomach cancer	3.05e-05	0.000134	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALB—stomach cancer	2.88e-05	0.000126	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—VEGFA—stomach cancer	2.82e-05	0.000124	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—STAT3—stomach cancer	2.79e-05	0.000122	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NOS3—stomach cancer	2.75e-05	0.000121	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MAPK3—stomach cancer	2.66e-05	0.000117	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MYC—stomach cancer	2.59e-05	0.000114	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MAPK1—stomach cancer	2.53e-05	0.000111	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EGFR—stomach cancer	2.53e-05	0.000111	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PTGS2—stomach cancer	2.52e-05	0.000111	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KRAS—stomach cancer	2.39e-05	0.000105	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3CA—stomach cancer	2.2e-05	9.66e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TP53—stomach cancer	2.13e-05	9.34e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HRAS—stomach cancer	2.04e-05	8.94e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL6—stomach cancer	1.95e-05	8.55e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.55e-05	6.8e-05	CbGpPWpGaD
